NCT05378269View on ClinicalTrials.gov

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 22, 2021

Primary Completion Date

December 20, 2022

Study Completion Date

March 1, 2023

Conditions
Vulvar Atrophy
Interventions
DRUG

Tamoxifen

Tamoxifen vaginal insert

OTHER

Placebo

Placebo vaginal insert

Trial Locations (2)

5000

PARC Clinical Research, Adelaide

6009

Keogh Institute for Medical Research, Nedlands

Sponsors
All Listed Sponsors
lead

Daré Bioscience, Inc.

INDUSTRY